S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide

S100A4 (metastasin-1), a metastasis-associated protein and marker of the epithelial to mesenchymal transition, contributes to several hallmarks of cancer and has been implicated in the progression of several types of cancer. However, the impacts of S100A4 signaling in lung cancer progression and its...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Stewart, Rachel L., Carpenter, Brittany L., West, Dava S., Knifley, Teresa, Liu, Lili, Wang, Chi, Weiss, Heidi L., Gal, Tamas S., Durbin, Eric B., Arnold, Susanne M., O'Connor, Kathleen L., Chen, Min
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5085181/
https://ncbi.nlm.nih.gov/pubmed/27127879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8969
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados